Correlation Between Pliant Therapeutics and Arcellx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Arcellx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Arcellx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Arcellx, you can compare the effects of market volatilities on Pliant Therapeutics and Arcellx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Arcellx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Arcellx.

Diversification Opportunities for Pliant Therapeutics and Arcellx

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Pliant and Arcellx is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Arcellx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcellx and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Arcellx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcellx has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Arcellx go up and down completely randomly.

Pair Corralation between Pliant Therapeutics and Arcellx

Given the investment horizon of 90 days Pliant Therapeutics is expected to under-perform the Arcellx. But the stock apears to be less risky and, when comparing its historical volatility, Pliant Therapeutics is 1.2 times less risky than Arcellx. The stock trades about -0.14 of its potential returns per unit of risk. The Arcellx is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  8,499  in Arcellx on August 27, 2024 and sell it today you would earn a total of  442.00  from holding Arcellx or generate 5.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pliant Therapeutics  vs.  Arcellx

 Performance 
       Timeline  
Pliant Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Pliant Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Pliant Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Arcellx 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Arcellx are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting essential indicators, Arcellx showed solid returns over the last few months and may actually be approaching a breakup point.

Pliant Therapeutics and Arcellx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pliant Therapeutics and Arcellx

The main advantage of trading using opposite Pliant Therapeutics and Arcellx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Arcellx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcellx will offset losses from the drop in Arcellx's long position.
The idea behind Pliant Therapeutics and Arcellx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Insider Screener
Find insiders across different sectors to evaluate their impact on performance